About LARALAB
LARALAB, a healthcare AI company, specializes in developing advanced image-based software and a cloud-based platform, heart.ai, designed to significantly enhance procedural planning and guidance for heart interventions. For physicians, this platform offers a robust tool for analyzing complex medical image data, such as cardiac CT scans, to automatically segment various anatomical structures of the heart. This automation aids in precisely determining optimal puncture sites, selecting suitable catheters, and identifying appropriate implants for individual patients undergoing transcatheter therapies, including Mitral, Tricuspid, and Aortic Valve procedures.
The company’s technology aims to streamline the pre-procedural assessment workflow, providing instant screening results without extensive manual workup. This capability is crucial for improving efficiency in both routine patient care and clinical trials, ultimately leading to more timely and effective treatment decisions. LARALAB has also introduced ‘REC – Rapid Eligibility Check,’ an AI-driven tool for quick patient eligibility assessments, further supporting structural heart teams in identifying viable treatment pathways and optimizing patient selection for interventions.
Focus Areas
Business Intelligence
| Key Investors | EIT Health, Philips HealthWorks, Xpreneurs |
| Partnerships | Columbia University (TTVR-AHI Registry), HDZ Bad Oeynhausen (CESAR-TR Registry), LMU Hospital (Generative AI for Cardiac Treatments), Abbott (TMVR screening collaboration), Philips Global AI start-up program |
| Acquisitions | Acquired by Abbott Laboratories on October 27, 2025 |
| Technology | Proprietary deep learning and cloud technology, cloud-native deployment, web-based medical viewer, AI operating system |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, LARALAB's platform offers significant time savings through rapid, AI-driven pre-screening and eligibility checks, allowing focus on viable treatment pathways and eliminating ineligible options quickly. The high-precision, automated CT analysis and comprehensive coverage across all major heart valves enhance diagnostic accuracy and support personalized procedural planning for transcatheter therapies. Regulatory clearances (FDA 510(k) and CE mark) provide confidence in clinical application, while interpretable reports facilitate understanding and communication. The cloud-native deployment ensures accessibility and scalability, making it a valuable tool for optimizing workflows and improving patient outcomes in interventional cardiology.
LARALAB's heart.ai platform is designed for cloud-native deployment, offering a secure and scalable solution for integration within hospital systems, research organizations, and device companies. It is DICOM compliant, ensuring seamless import and processing of medical images. The company's acquisition by Abbott in October 2025 suggests potential for deeper integration with Abbott's existing structural heart portfolio and digital health offerings.
Reviews & Opinions
Videos
News, demos, and interviews about LARALAB.
Videos load interactively. If none appear, search YouTube for LARALAB →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded LARALAB.
Related Companies
Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
Oxipit, now a part of the Sectra Group, is a leading healthcare AI company specializing in AI-driven medical imaging solutions for radiology. Founded by experts in medicine and data science, the company aims to address the global shortage of radiologists and improve diagnostic efficiency and accuracy. Their flagship product line, the CXR Suite, includes CE-certified […]
Meril Life Sciences is an Indian multinational medical device company dedicated to the innovation, design, and development of clinically relevant and state-of-the-art devices. The company focuses on alleviating human suffering and improving the quality of life through advanced healthcare solutions. Meril’s extensive product portfolio spans various medical fields, including vascular intervention, orthopedic implants, robotics, endosurgery, […]
Cercare Medical is an AI-powered healthcare company specializing in advanced perfusion imaging solutions for neurological diseases. Their software, the Cercare Medical Neurosuite, processes CT, CBCT, and MRI data to provide detailed insights into brain health. This technology goes beyond traditional perfusion imaging by integrating proprietary biomarkers that measure not only blood flow but also oxygenation, […]
CARPL.ai is a vendor-neutral Artificial Intelligence (AI) platform designed to empower radiologists by providing a unified interface for accessing, assessing, integrating, and monitoring AI solutions within their clinical workflows. The platform addresses the challenges healthcare providers face in navigating the fragmented landscape of numerous AI applications by offering a single point of access, data channel, […]
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]